CombiMatrix and Benitec Enter Cross-Licensing Agreement for siRNA, HIV Sequences | GenomeWeb

NEW YORK, Feb. 23 (GenomeWeb News) - CombiMatrix and Benitec announced yesterday that they have entered into a cross-licensing agreement covering a variety of projects.

Through the agreement, CombiMatrix will issue a non-exclusive license to Benitec for its intellectual property rights related to the use of pools of siRNAs, or cocktails, as therapeutic agents against viral diseases.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.